Myovant to receive an upfront payment of US $50 million, is eligible to receive commercial launch, sales-based and other milestones totaling up to US $90.5 million
RNAstorm and DNAstorm RNA/DNA extraction kits will be sold exclusively through the Biotium website and authorized distributors
This partnership expands DNA Script’s footprint and provides sales and support for the SYNTAX System DNA printer in labs in India
_256_384.jpg)
The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings
This is the first major brand refresh of CanSinoBIO since its inception in 2009
Terran to advance the development of two of Sanofi's Phase 3 CNS therapeutics
Under the terms of the partnership agreement, Comera will develop a differentiated formulation of an Intas product using Comera's innovative proprietary SQore formulation platform
The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat
Shoreline has developed a proprietary methodology to create differentiated iNK cells for large-scale, "off-the-shelf" production
Immunocin, an Immuno-modulator drug, significantly reduced the risk of death in the Phase 3 clinical trial in adult patients with moderate-to-severe Covid-19
Subscribe To Our Newsletter & Stay Updated
